Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
Bin Zheng, Wenchang Peng, Mingming Guo, et al.
Chemical Engineering Journal (2021) Vol. 418, pp. 129392-129392
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Emerging vaccine nanotechnology: From defense against infection to sniping cancer
Chan Feng, Yongjiang Li, Bijan Emiliano Ferdows, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 5, pp. 2206-2223
Open Access | Times Cited: 87
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
Renee W. Y. Chan, Shaojun Liu, Jonathan Y. Cheung, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 82
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu, Hannah G. Kelly, Stephen J. Kent, et al.
EBioMedicine (2021) Vol. 74, pp. 103699-103699
Open Access | Times Cited: 80
A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
Shao‐Hua Zhuo, Jun Wu, Lang Zhao, et al.
Nano Research (2022) Vol. 15, Iss. 5, pp. 4191-4200
Open Access | Times Cited: 39
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 10
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 8
Multifaceted therapeutic applications of biomimetic nanovaccines
Dev Chheda, Sukhen Shete, Tanisha Tanisha, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103991-103991
Open Access | Times Cited: 7
Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery
Yuhong Lin, Beini Sun, Zheng Jin, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 47, pp. 52691-52701
Closed Access | Times Cited: 34
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 20
Nanoparticles exhibiting virus-mimic surface topology for enhanced oral delivery
Zhentao Sang, Lu Xu, Renyu Ding, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals
Mohammad Al‐Tamimi, Amjed A. Tarifi, Arwa Qaqish, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281689-e0281689
Open Access | Times Cited: 16
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16
Pulmonary Infection-Adapted Biomimetic Vesicles for Targeted Icariin Delivery to Combat Pneumonia Induced by Mycoplasma
Haijun Gong, Jinhu Chen, Jing Zhang, et al.
(2025)
Closed Access
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Vaccine design and delivery approaches for COVID-19
Kiana Shahzamani, Fatemeh Mahmoudian, Shahrzad Ahangarzadeh, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108086-108086
Open Access | Times Cited: 34
In situ sprayed hydrogels containing resiquimod-loaded liposomes reduce chronic osteomyelitis recurrence by intracellular bacteria clearance
Liangjie Tian, Zilin Tan, Yusheng Yang, et al.
Acta Biomaterialia (2023) Vol. 169, pp. 209-227
Open Access | Times Cited: 13
Virus-like structures for combination antigen protein mRNA vaccination
Jingjing Zhang, Yanmei Li, Fengyuan Zeng, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1224-1233
Open Access | Times Cited: 4
Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development
Elidamar Nunes de Carvalho Lima, Ricardo Sobhie Diaz, João F. Justo, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 5411-5435
Open Access | Times Cited: 30
Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy
Weili Yang, Qi Li, Jing Sun, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2442-2454
Open Access | Times Cited: 20
Nanovaccines against Viral Infectious Diseases
Wen Tzuen Heng, Jia Sheng Yew, Chit Laa Poh
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2554-2554
Open Access | Times Cited: 20
Recent progress in application of nanovaccines for enhancing mucosal immune responses
Guangsheng Du, Ming Qin, Xun Sun
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 6, pp. 2334-2345
Open Access | Times Cited: 19
SIgA in various pulmonary diseases
Xintian Wang, Jun Zhang, Yan Wu, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11
Inhalation drug delivery in combating pulmonary infections: Advances and challenges
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105022-105022
Closed Access | Times Cited: 11
Expanding opportunities to engineer mucosal vaccination with biomaterials
Helena Freire Haddad, Emily F. Roe, Joel H. Collier
Biomaterials Science (2023) Vol. 11, Iss. 5, pp. 1625-1647
Closed Access | Times Cited: 10
Exosomes-based particles as inhalable COVID-19 vaccines
Fan Lü, Li Wang, Xiaoju Wang, et al.
Biomedical Technology (2023) Vol. 4, pp. 24-27
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top